May 11, 2021 / 09:00PM GMT
Ashwani Verma - BofA Securities, Research Division - Research Analyst
Hello, everyone. Welcome to Bank of America 2021 Virtual Health Care Conference. My name is Ashwani Verma. I cover biotech companies here at Bank of America. The next company on our virtual stage is Intra-Cellular Therapies. And joining me today from Intra-Cellular is Dr. Sharon Mates and Mark Neumann.
Sharon, just I think it would be helpful if you can give a brief overview of the company before we get into the Q&A session.
Sharon Mates - Intra-Cellular Therapies, Inc. - Co-Founder, Chairman, CEO & President
Great. Thanks, Ash. It's a pleasure to be here today to tell you our story. First, I will be making forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ. I refer you to our website and to our SEC filings for updates on the company.
I know many of you know us, but let me start with just a brief background on our company. Intra-Cellular Therapies was founded in 2002, using technology-based
Intra-Cellular Therapies Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot